CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleMarket cap is $1.86B, above the global median of $1.18B
- PositionGross margin is 72.1%, higher than 95% of its Medical Instruments & Supplies peers (median 44.7%)
- Interpretations8 currently firing — 8
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.22%Above 5Y avg (0.88%)
Annual Rate
USD 1.00Paid quarterly
Payout Ratio
31.5%Sustainable
Consecutive Growth
12 yrStrong track record
Paying Dividends
14 yr
Payback Period
83.1 yr
Last Ex-Dividend
Aug 20, 2026
Last Payment
Sep 3, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.86BUSDvs all stocks (USD)
Trailing P/E
28.50xvs Medical Instruments & Supplies peers
Revenue (TTM)
262.43MUSDvs all stocks (USD)
Profit Margin
25.02%vs Medical Instruments & Supplies peers
Beta
0.4930xvs all stocks
52-Week Change
-4.60%vs all stocks
Forward Annual Dividend Yield
1.22%vs all stocks
Market Capitalization
1.86BUSDvs all stocks (USD)
Enterprise Value
1.68BUSDvs all stocks (USD)
Trailing P/E
28.50xvs Medical Instruments & Supplies peers
Forward P/E
25.65xvs Medical Instruments & Supplies peers
PEG Ratio
1.24xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
7.10xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
4.43xvs Medical Instruments & Supplies peers
Enterprise to Revenue
6.39xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
20.22xvs Medical Instruments & Supplies peers
Gross Margin
72.13%vs Medical Instruments & Supplies peers
Profit Margin
25.02%vs Medical Instruments & Supplies peers
Operating Margin
28.98%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
7.44%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
16.77%vs Medical Instruments & Supplies peers
Revenue (TTM)
262.43MUSDvs all stocks (USD)
Revenue per Share (TTM)
11.53USDUpdated Sep 27, 2026Quarterly Revenue Growth
9.60%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
188.60MUSDvs all stocks (USD)
EBITDA (TTM)
97.11MUSDvs all stocks (USD)
Net Income (TTM)
65.67MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
23.70%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
82.98MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
49.26MUSDvs all stocks (USD)
Forward Annual Dividend Rate
1.00USDUpdated Sep 27, 2026Forward Annual Dividend Yield
1.22%vs all stocks
Trailing Annual Dividend Rate
0.9500USDUpdated Sep 27, 2026Trailing Annual Dividend Yield
1.16%vs all stocks
5-Year Average Dividend Yield
0.88%vs all stocks
Payout Ratio
31.47%vs Medical Instruments & Supplies peers
Revenue
249.60MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
71.06MUSDFY2025 · Dec 31, 2025Gross Profit
178.54MUSDFY2025 · Dec 31, 2025Operating Income
67.91MUSDvs all stocks (USD)
Pre-tax Income
75.18MUSDFY2025 · Dec 31, 2025Income Tax Expense
17.45MUSDFY2025 · Dec 31, 2025Net Income
57.73MUSDFY2025 · Dec 31, 2025EBIT
80.37MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
77.69MUSDFY2025 · Dec 31, 2025Research & Development
14.14MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
96.49MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
5.18MUSDFY2025 · Dec 31, 2025EPS (Basic)
2.55USDFY2025 · Dec 31, 2025EPS (Diluted)
2.52USDFY2025 · Dec 31, 2025Basic Shares Outstanding
22.64MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
22.64MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
57.73MUSDFY2025 · Dec 31, 2025Operating Cash Flow
73.19MUSDFY2025 · Dec 31, 2025Free Cash Flow
66.41MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
28.24MUSDFY2025 · Dec 31, 2025Income Tax Paid
13.44MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
57.73MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
10.42MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
2.31MUSDFY2025 · Dec 31, 2025Stock-based Compensation
7.83MUSDFY2025 · Dec 31, 2025Other Non-cash Items
873.00KUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-2.95MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
4.20MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-7.22MUSDFY2025 · Dec 31, 2025Capital Expenditures
-6.78MUSDFY2025 · Dec 31, 2025Net Acquisitions
-1.90MUSDFY2025 · Dec 31, 2025Purchase of Investments
-641.33MUSDFY2025 · Dec 31, 2025Sale of Investments
585.07MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-64.94MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
0.00USDFY2025 · Dec 31, 2025Common Dividends Paid
-18.11MUSDFY2025 · Dec 31, 2025Other Financing Charges
-1.43MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-19.54MUSDFY2025 · Dec 31, 2025Shares Outstanding
22.86MSharesUpdated Sep 27, 2026Float Shares
21.30MSharesUpdated Sep 27, 2026Shares Short
1.69MSharesUpdated Sep 27, 2026Short Ratio
5.68daysvs all stocks
Short % of Shares Outstanding
9.31%vs all stocks
% Held by Insiders
6.52%vs all stocks
% Held by Institutions
103.82%vs all stocks
Total Cash (MRQ)
376.24MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
16.45USDUpdated Sep 27, 2026Total Debt (MRQ)
190.25MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.4526xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
16.31xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
18.38USDUpdated Sep 27, 2026Total Assets
615.69MUSDvs all stocks (USD)
Total Current Assets
468.23MUSDFY2025 · Dec 31, 2025Total Liabilities
222.17MUSDFY2025 · Dec 31, 2025Total Non-current Assets
147.46MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
185.85MUSDFY2025 · Dec 31, 2025Total Current Liabilities
36.32MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
28.24MUSDFY2025 · Dec 31, 2025Other Short-term Investments
330.88MUSDFY2025 · Dec 31, 2025Accounts Receivable
33.61MUSDFY2025 · Dec 31, 2025Inventory
58.25MUSDFY2025 · Dec 31, 2025Accounts Payable
3.65MUSDFY2025 · Dec 31, 2025Short-term Debt
2.94MUSDFY2025 · Dec 31, 2025Other Current Liabilities
322.00KUSDFY2025 · Dec 31, 2025Long-term Debt
182.65MUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
964.00KUSDFY2025 · Dec 31, 2025Common Stock (Book)
244.00KUSDFY2025 · Dec 31, 2025Retained Earnings
184.72MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
393.52MUSDvs all stocks (USD)
Treasury Stock
17.44MUSDFY2025 · Dec 31, 202552-Week Low
78.22USDUpdated Sep 27, 202652-Week High
118.01USDUpdated Sep 27, 202652-Week Change
-4.60%vs all stocks
Beta
0.4930xvs all stocks
50-Day MA
86.03USDUpdated Sep 27, 2026200-Day MA
94.65USDUpdated Sep 27, 2026Avg 10-Day Volume
269.32KSharesUpdated Sep 27, 2026Avg 30-Day Volume
298.47KSharesUpdated Sep 27, 2026Diluted EPS (TTM)
2.86USDUpdated Sep 27, 2026Other Income / Expense
12.46MUSDFY2025 · Dec 31, 20258 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Cash Backing With Revenue And Income Streaks
Revenue has risen in each of three years, profit in all three, and it holds more cash than debt.
Reads
Cash-Flow Ratios Elevated
More of its sales turn into cash than in its industry, and less of that cash is consumed by reinvestment than at most of its peers.
Reads
FCF Ratios Elevated
Its free cash flow is large next to assets and equity, and more of its operating cash reaches it than in its industry.
Reads
Industry-Benchmarked ROA and Margin Elevated
Returns and margins have sat in the top of its industry across five years.
Reads
Multi-Year FCF With Growth And Margin
Three years of positive free cash flow and rising revenue, four of rising equity, and much of its sales turns into cash.
Reads
Revenue Growing With Receivables Growing
Revenue has risen three years, and what customers owe has risen with it.
Reads
Is this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
How is this stock valued?
Near 52W Low With Profitability And FCF
Within 1% of its 52-week low, profitable three years, and capex takes less of its cash flow than at most of its peers.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Gross margin is 72.1%, higher than 95% of its Medical Instruments & Supplies peers (median 44.7%)Significant
Gross margin: 0.72Industry median: 0.45Industry P95: 0.72Peers compared: 62.00
Operating margin is 29%, higher than 95% of its Medical Instruments & Supplies peers (median 11.9%)Significant
Operating margin: 0.29Industry median: 0.12Industry P95: 0.28Peers compared: 62.00
Profit margin is 25%, higher than 95% of its Medical Instruments & Supplies peers (median 8.7%)Significant
Profit margin: 0.25Industry median: 0.09Industry P95: 0.25Peers compared: 62.00
Current ratio is 16.31×, higher than 95% of its Medical Instruments & Supplies peers (median 2.2×)Significant
Current ratio: 16.31Industry median: 2.20Industry P95: 10.55Peers compared: 62.00
Financial Health
Altman Z-Score 7.13: safe zoneNotable
Altman Z-Score: 7.13
High earnings qualityNotable
Earnings Quality Score: 0.90
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $1.86B, above the global median of $1.18BNotable
Market cap (USD): 1,864,301,830Global Median: 1,180,223,658.953
Levered free cash flow is $49.26M, above the global median of $18.73MNotable
Levered free cash flow (USD): 49,263,624Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Jiangsu Changling Hydraulic Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Huaxia Eye Hospital Group Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Olin Corporation
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shenzhen Qingyi Photomask Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Shandong Pharmaceutical Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Jiangsu Cnano Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Azad Engineering Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Ningbo Yunsheng (Group) Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Wintech-Nano Suzhou Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Expro Group Holdings N.V.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Companies that share active interpretations — structural patterns currently present in both stocks.
Global Ship Lease Inc.
7 interpretationsCash Backing With Revenue And Income StreaksFCF Ratios ElevatedCash-Flow Ratios ElevatedRevenue Growing With Receivables GrowingMulti-Year Revenue, Profit, And Income GrowthIndustry-Benchmarked ROA and Margin ElevatedMulti-Year FCF With Growth And Margin
Intuitive Surgical, Inc.
7 interpretationsCash Backing With Revenue And Income StreaksFCF Ratios ElevatedCash-Flow Ratios ElevatedRevenue Growing With Receivables GrowingMulti-Year Revenue, Profit, And Income GrowthIndustry-Benchmarked ROA and Margin ElevatedMulti-Year FCF With Growth And Margin
United States Lime & Minerals Inc.
7 interpretationsCash Backing With Revenue And Income StreaksFCF Ratios ElevatedCash-Flow Ratios ElevatedRevenue Growing With Receivables GrowingMulti-Year Revenue, Profit, And Income GrowthIndustry-Benchmarked ROA and Margin ElevatedMulti-Year FCF With Growth And Margin